CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future

In recent years, with the breakthrough of CAR-T cells in the treatment of hematological tumors, they are increasingly being used to treat solid tumors, including urologic neoplasms. There are many relatively specific targets for urologic neoplasms, especially prostate cancer. Besides, urologic neopl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhengchao, Li, Dong, Yun, Heng, Liu, Wei, Chai, Keqiang, Tong, Jie, Zeng, Tongwei, Gao, Zhenghua, Xie, Yongqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292130/
https://www.ncbi.nlm.nih.gov/pubmed/35860578
http://dx.doi.org/10.3389/fonc.2022.915171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292130/
https://www.ncbi.nlm.nih.gov/pubmed/35860578
http://dx.doi.org/10.3389/fonc.2022.915171

Ejemplares similares